This website uses cookies to enhance the user experience.
||
E

EUROFINS BIOPHARMA PRODUCT TESTING NORWAY AS931 468 065

Limited company
Møllebakken 40 1538 MOSS, Norge

EUROFINS BIOPHARMA PRODUCT TESTING NORWAY AS

Organization

CEO
JR
Chairman of the board
Years since formation
2 years
since Sep 7, 2023
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
1,224,824
NOK
Annual total result 2024
348,311
NOK
Total equity 2024
695,655
NOK
Last update: Sep 9, 2025

Management

Management / administration

NameRoleShares
JR
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
ResignedBoard Member-

Others

NameRoleShares
D
DELOITTE AS
Auditor-
Last update: Jun 27, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
30,000
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year20242023
Total operating income
1,224,824
312,022
Annual Total Result
348,311
1,225
Total assets
1,342,130
759,273
Total liabilities
646,474
63,619
Total equity
695,655
695,655

P&L

Year20242023
Total operating income
1,224,824
312,022
Total operating costs
773,177
312,022
Operating result
451,647
0
Financial income/costs
-5,095
0
Profit before tax
446,552
0
Total tax & extraordinary income/cost
98,241
-1,225
Annual Total Result
348,311
1,225

Balance overview

Year20242023
Total fixed assets
0
1,225
Total current assets
1,342,130
758,048
Total assets
1,342,130
759,273
Short term debt
646,474
63,619
Long term debt
0
0
Total liabilities
646,474
63,619
Contributed capital
694,430
694,430
Retained earnings
1,225
1,225
Total equity
695,655
695,655
Total equity and liabilities
1,342,130
759,273

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises